R K D Pharmaceutical LLP is a globally focused pharmaceutical export and healthcare sourcing company providing access to high-quality pharmaceutical formulations, APIs, excipients, nutraceuticals, medical devices, surgical consumables, laboratory ins...
- (+91) 9004316713
- ajay.sharma@rkdpharmaceutical.com
- Unit no.414, 4th Floor, Marathon Max, Mulund – Goregaon Link road, Mulund West, , Mumbai, Maharashtra, India. 400080
© 2020 R K D PHARMACEUTICAL LLP. All Rights Reserved
Amoxicillin Trihydrate BP 875 mg & Potassium Clavulanate BP 125 mg
-
Product is not available
Country of origin : India
Strength & Pharmacopoeial Grade
Amoxicillin Trihydrate BP 875 mg & Potassium Clavulanate BP 125 mg is a fixed-dose antibacterial combination intended for oral tablet formulations. Each stated dose provides amoxicillin equivalent to 875 mg as amoxicillin trihydrate and clavulanic acid equivalent to 125 mg as potassium clavulanate. Pharmaceutical and institutional buyers should verify the finished-product specification, batch certificate of analysis (COA), registration status and applicable supply documentation before procurement.
Composition & Product Characteristics
The formulation combines a penicillin-class antibacterial, amoxicillin, with clavulanic acid supplied as potassium clavulanate, a beta-lactamase inhibitor. Procurement assessment should cover identity, assay, related substances, dissolution, microbial quality, tablet characteristics and packaging integrity against the approved specification. Excipients, storage conditions, pack configuration and market-specific labelling should be confirmed from the manufacturer’s technical dossier and batch documentation.
-
Additional Information
Formulation Application & Compatibility
This product is part of our Pharmaceutical Products range for pharmaceutical distributors, institutional procurement teams and regulated-market buyers. The 875 mg/125 mg fixed-dose combination is generally supplied as an oral film-coated tablet containing amoxicillin as amoxicillin trihydrate and clavulanic acid as potassium clavulanate. Procurement teams should match the offered product specification, dosage form, excipient profile, packaging and batch COA with their destination-market registration and tender requirements. This prescription medicine must be supplied and used in accordance with applicable regulations and qualified healthcare guidance.
- Country of Origin: Confirm from the manufacturer or supplier
- Regulatory/Pharmacopoeial Compliance: Active ingredients stated as BP grade; finished-product compliance and market authorization must be confirmed from supporting documentation
- Quality Assurance / Shelf Life: Confirm batch-release testing, approved storage conditions and labelled shelf life from the COA and manufacturer documentation
Manufacturing Compliance & Documentation
Request an Amoxicillin Trihydrate BP 875 mg & Potassium Clavulanate BP 125 mg Procurement Quote
Frequently Asked Questions
- What are the minimum order quantities and bulk order options for Amoxicillin Trihydrate BP 875 mg & Potassium Clavulanate BP 125 mg? Minimum order quantities depend on the manufacturer, pack configuration, destination market and registration requirements. Buyers should share their required volume, pack size and delivery schedule to confirm available bulk-order options.
- How is pricing structured for large-volume purchases? Pricing may vary according to order volume, packaging format, destination, documentation requirements and shipment terms. Provide the required quantity and Incoterm to obtain an appropriate commercial quotation.
- Are COA and pharmacopoeial documents available for this product? Document availability should be confirmed before ordering. Buyers may request the batch COA, product specification, manufacturing authorization, stability information and other documents required for registration, tendering or import clearance.
- What logistics and lead-time considerations apply to shipments? Lead time depends on production availability, batch-release testing, packaging, regulatory documentation and the destination country’s import procedures. Storage and transportation conditions must follow the manufacturer’s approved product labelling.
-
Reviews ()
Write a Review
